Press Releases

Mar 23, 2015 07:10 EDT www.wiseguyreports.com The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world.

Mar 23, 2015 06:42 EDT www.wiseguyreports.com Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO).

Mar 23, 2015 06:11 EDT www.wiseguyreports.com “Pilonidal Sinus Global Clinical Trials Review, H1, 2015" provides data on the Pilonidal Sinus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pilonidal Sinus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Mar 23, 2015 05:45 EDT www.wiseguyreports.com Clinical trial report, “​Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H1, 2015" provides data on the ​Glycogen Storage Disorders (GSD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ​Glycogen Storage Disorders (GSD).

Mar 23, 2015 05:09 EDT www.wiseguyreports.com This report provides elemental information and data relating to the clinical trials on Glomerulonephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Mar 23, 2015 04:32 EDT www.wiseguyreports.com This report provides elemental information and data relating to the clinical trials on Cystinosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Mar 23, 2015 03:35 EDT www.wiseguyreports.com This report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemiplegia.

Mar 23, 2015 02:22 EDT www.wiseguyreports.com The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% and generating around 68% of global sales in 2018, the US market will experience twice the rate of growth of the 5EU market.

Mar 19, 2015 17:08 EDT www.wiseguyreports.com This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Mar 19, 2015 16:51 EDT www.wiseguyreports.com This report provides comprehensive information on the therapeutic development for Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.